TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,384,000 | +141.1% | 97,400 | +37.4% | 0.01% | +66.7% |
Q2 2020 | $574,000 | +8100.0% | 70,900 | +193.7% | 0.00% | – |
Q3 2019 | $7,000 | -22.2% | 24,138 | -8.7% | 0.00% | – |
Q2 2019 | $9,000 | -74.3% | 26,438 | -50.8% | 0.00% | – |
Q1 2019 | $35,000 | 0.0% | 53,728 | +164.7% | 0.00% | – |
Q4 2018 | $35,000 | – | 20,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
Artal Group S.A. | 150,000 | $870,000 | 0.02% |
Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |